|
Originally published In Press as doi:10.1074/jbc.M501365200 on April 19, 2005
J. Biol. Chem., Vol. 280, Issue 25, 23778-23784, June 24, 2005
Desmosome Signaling
INHIBITION OF p38MAPK PREVENTS PEMPHIGUS VULGARIS IgG-INDUCED CYTOSKELETON REORGANIZATION*
Paula Berkowitz ,
Peiqi Hu ,
Zhi Liu ,
Luis A. Diaz ,
Jan J. Enghild ,
Michael P. Chua¶, and
David S. Rubenstein ||**
From the
Departments of Dermatology and ¶Cell and Molecular Physiology and the ||Lineberger Comprehensive Cancer Center University of North Carolina-Chapel Hill School of Medicine, Chapel Hill, North Carolina 27599 and the Department of Molecular Biology, University of Aarhus, DK-8000 Århus, Denmark
In the human autoimmune blistering disease pemphigus vulgaris (PV) pathogenic antibodies bind the desmosomal cadherin desmoglein-3 (dsg3), causing epidermal cell-cell detachment (acantholysis). Pathogenic PV dsg3 autoantibodies were used to initiate desmosome signaling in human keratinocyte cell cultures. Heat shock protein 27 (HSP27) and p38MAPK were identified as proteins rapidly phosphorylated in response to PV IgG. Inhibition of p38MAPK activity prevented PV IgG-induced HSP27 phosphorylation, keratin filament retraction, and actin reorganization. These observations suggest that PV IgG binding to dsg3 activates desmosomal signal transduction cascades leading to (i) p38MAPK and HSP27 phosphorylation and (ii) cytoskeletal reorganization, supporting a mechanistic role for signaling in PV IgG-induced acantholysis. Targeting desmosome signaling via inhibition of p38MAPK and HSP27 phosphorylation may provide novel treatments for PV and other desmosome-associated blistering diseases.
Received for publication, February 4, 2005
, and in revised form, April 13, 2005.
* This work was supported by National Institutes of Health Grants RO1 AI49427-01 (to D. S. R.) and RO1 AR30281, RO1AR32599, and T32 AR07369 (to L. A. D.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
** To whom correspondence should be addressed: Dept. of Dermatology, University of North Carolina-Chapel Hill School of Medicine, Suite 3100 Thurston-Bowles Bldg. CB 7287, Chapel Hill, NC 27599-7287. Tel.: 919-843-7092; Fax: 919-966-3898; E-mail: druben{at}med.unc.edu.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
H. E. Lee, P. Berkowitz, P. S. Jolly, L. A. Diaz, M. P. Chua, and D. S. Rubenstein
Biphasic Activation of p38MAPK Suggests That Apoptosis Is a Downstream Event in Pemphigus Acantholysis
J. Biol. Chem.,
May 1, 2009;
284(18):
12524 - 12532.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W.-M. Heupel, P. Engerer, E. Schmidt, and J. Waschke
Pemphigus Vulgaris IgG Cause Loss of Desmoglein-Mediated Adhesion and Keratinocyte Dissociation Independent of Epidermal Growth Factor Receptor
Am. J. Pathol.,
February 1, 2009;
174(2):
475 - 485.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Li, M. Zhao, J. Wang, Z. Liu, and L. A. Diaz
Involvement of the Apoptotic Mechanism in Pemphigus Foliaceus Autoimmune Injury of the Skin
J. Immunol.,
January 1, 2009;
182(1):
711 - 717.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Schmidt, J. Gutberlet, D. Siegmund, D. Berg, H. Wajant, and J. Waschke
Apoptosis is not required for acantholysis in pemphigus vulgaris
Am J Physiol Cell Physiol,
January 1, 2009;
296(1):
C162 - C172.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Berkowitz, M. Chua, Z. Liu, L. A. Diaz, and D. S. Rubenstein
Autoantibodies in the Autoimmune Disease Pemphigus Foliaceus Induce Blistering via p38 Mitogen-Activated Protein Kinase-Dependent Signaling in the Skin
Am. J. Pathol.,
December 1, 2008;
173(6):
1628 - 1636.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Vidyasagar, S. Reese, Z. Acun, D. Hullett, and A. Djamali
HSP27 is involved in the pathogenesis of kidney tubulointerstitial fibrosis
Am J Physiol Renal Physiol,
September 1, 2008;
295(3):
F707 - F716.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. R. W. Plano, S. C. Davis, and P. M. Mertz
Panton-Valentine Leukocidin, Exfoliative Toxins, and Skin Infections--Reply
Arch Dermatol,
August 1, 2008;
144(8):
1070 - 1070.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W.-M. Heupel, D. Zillikens, D. Drenckhahn, and J. Waschke
Pemphigus Vulgaris IgG Directly Inhibit Desmoglein 3-Mediated Transinteraction
J. Immunol.,
August 1, 2008;
181(3):
1825 - 1834.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Delva, J. M. Jennings, C. C. Calkins, M. D. Kottke, V. Faundez, and A. P. Kowalczyk
Pemphigus Vulgaris IgG-induced Desmoglein-3 Endocytosis and Desmosomal Disassembly Are Mediated by a Clathrin- and Dynamin-independent Mechanism
J. Biol. Chem.,
June 27, 2008;
283(26):
18303 - 18313.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. I. Chernyavsky, J. Arredondo, T. Piser, E. Karlsson, and S. A. Grando
Differential Coupling of M1 Muscarinic and {alpha}7 Nicotinic Receptors to Inhibition of Pemphigus Acantholysis
J. Biol. Chem.,
February 8, 2008;
283(6):
3401 - 3408.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. M. Mertz, T. C. P. Cardenas, R. V. Snyder, M. A. Kinney, S. C. Davis, and L. R. W. Plano
Staphylococcus aureus Virulence Factors Associated With Infected Skin Lesions: Influence on the Local Immune Response
Arch Dermatol,
October 1, 2007;
143(10):
1259 - 1263.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Spindler, D. Drenckhahn, D. Zillikens, and J. Waschke
Pemphigus IgG Causes Skin Splitting in the Presence of Both Desmoglein 1 and Desmoglein 3
Am. J. Pathol.,
September 1, 2007;
171(3):
906 - 916.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Woll, R. Windoffer, and R. E. Leube
p38 MAPK-dependent shaping of the keratin cytoskeleton in cultured cells
J. Cell Biol.,
June 21, 2007;
177(5):
795 - 807.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Yamamoto, Y. Aoyama, E. Shu, K. Tsunoda, M. Amagai, and Y. Kitajima
Anti-desmoglein 3 (Dsg3) Monoclonal Antibodies Deplete Desmosomes of Dsg3 and Differ in Their Dsg3-depleting Activities Related to Pathogenicity
J. Biol. Chem.,
June 15, 2007;
282(24):
17866 - 17876.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. I. Chernyavsky, J. Arredondo, Y. Kitajima, M. Sato-Nagai, and S. A. Grando
Desmoglein Versus Non-desmoglein Signaling in Pemphigus Acantholysis: CHARACTERIZATION OF NOVEL SIGNALING PATHWAYS DOWNSTREAM OF PEMPHIGUS VULGARIS ANTIGENS
J. Biol. Chem.,
May 4, 2007;
282(18):
13804 - 13812.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Qian, L. A. Diaz, J. Ye, and S. H. Clarke
Dissecting the Anti-Desmoglein Autoreactive B Cell Repertoire in Pemphigus Vulgaris Patients
J. Immunol.,
May 1, 2007;
178(9):
5982 - 5990.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Waschke, V. Spindler, P. Bruggeman, D. Zillikens, G. Schmidt, and D. Drenckhahn
Inhibition of Rho A activity causes pemphigus skin blistering
J. Cell Biol.,
December 4, 2006;
175(5):
721 - 727.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. R. Stanley and M. Amagai
Pemphigus, Bullous Impetigo, and the Staphylococcal Scalded-Skin Syndrome
N. Engl. J. Med.,
October 26, 2006;
355(17):
1800 - 1810.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Berkowitz, P. Hu, S. Warren, Z. Liu, L. A. Diaz, and D. S. Rubenstein
p38MAPK inhibition prevents disease in pemphigus vulgaris mice
PNAS,
August 22, 2006;
103(34):
12855 - 12860.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Hu, P. Berkowitz, V. J. Madden, and D. S. Rubenstein
Stabilization of Plakoglobin and Enhanced Keratinocyte Cell-Cell Adhesion by Intracellular O-Glycosylation
J. Biol. Chem.,
May 5, 2006;
281(18):
12786 - 12791.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. D. Kottke, E. Delva, and A. P. Kowalczyk
The desmosome: cell science lessons from human diseases.
J. Cell Sci.,
March 1, 2006;
119(Pt 5):
797 - 806.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Arredondo, A. I. Chernyavsky, A. Karaouni, and S. A. Grando
Novel Mechanisms of Target Cell Death and Survival and of Therapeutic Action of IVIg in Pemphigus
Am. J. Pathol.,
December 1, 2005;
167(6):
1531 - 1544.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|